Advocacy & News

COVID-19 Resource Center

Federal Agency Guidance and Resources to Address COVID-19

AMRPA FAQ on Waivers and Flexibilities (Members Only)

AMRPA Waiver Tracker Chart (Members Only)

Resources Available for Providers Related to COVID-19 Vaccine‎: 

On December 11, 2020, the U.S. Food and Drug Administration (FDA) issued the first emergency use ‎authorization (EUA) for a COVID-19 vaccine. The vaccine, developed by Pfizer-BioNTech, is now ‎approved for use in people 16 years of age and older. Based on recommendations from the Centers ‎for Disease Control and Prevention (CDC)’s Advisory Committee on Immunization Practices (ACIP) and it is ‎expected that frontline health care workers and long-term care facility residents will be eligible to begin ‎receiving vaccinations. The FDA issued the second EUA for a COVID-19 vaccine on December 20, 2020 The vaccine, developed by Moderna, is now ‎approved for use in people 18 years of age and older. Based on recommendations from the Centers ‎for Disease Control and Prevention (CDC)’s Advisory Committee on Immunization Practices (ACIP). A list of resources available to providers related to the vaccine are ‎available below:‎

Key Resources for IRFs:
Waivers and Other Provider Relief​

AMRPA COVID-19 Informational Call Series 


Financial Relief Resources

Medicare Payment Resources

Small Business & Paycheck Relief


Additional COVID-19 Resources

Health Care Providers

Prevention Resources

Reporting Resources